Loading…
Loading…
ATHA (Athira Pharma, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
ATHA does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ATHA and 80,000+ other tickers.
See exactly how ATHA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ATHA and 80,000+ other tickers.
Athira Pharma, Inc., a biopharmaceutical firm in advanced clinical development and based in Bothell, Washington, focuses on creating small molecule treatments designed to revitalize neuronal function and decelerate neurological decline. Its primary therapeutic candidate, ATH-1017, is a unique small molecule that modulates HGF/MET and is capable of crossing the blood-brain barrier. This compound is currently undergoing a Phase 3 clinical trial (LIFT-AD) and a Phase 2 clinical trial (ACT-AD) for Alzheimer's disease. Additionally, ATH-1017 is in Phase 2 clinical trials for Parkinson's disease…
Toronto, Ontario--(Newsfile Corp. - August 19, 2026) - Libra Energy Materials Inc. (CSE: LIBR) (OTCQB: LIBRF) (FSE: W0R0) ("Libra" or the "Company") is pleased to congratulate Athena Gold Corporation (CSE: ATHA) (OTCQB: AHNRF) ("Athena") on its recent gold discovery at its Laird Lake project, in Red Lake, Ontario (see Athena press release dated August 19, 2026). Libra remains a significant shareholder of Athena, holding >12% of Athena's common shares outstanding.
Toronto, Ontario--(Newsfile Corp. - August 19, 2026) - Athena Gold Corporation (CSE: ATHA) (OTCQB: AHNRF) ("Athena" or the "Company") is pleased to announce a near-surface, high-grade, grassroots gold discovery at its flagship Laird Lake project ("Laird" or the "Project") in Ontario's Red Lake Gold District. Hole LL-26-006A returned 23.85 g/t Au over 5 m, from 21.0 m to 26.0 m, defining the newly named Scooby Zone.
Toronto, Ontario--(Newsfile Corp. - August 12, 2026) - Athena Gold Corporation (CSE: ATHA) (OTCQB: AHNRF) ("Athena" or the "Company") is pleased to provide an exploration update from its Excelsior Springs Project ("Excelsior" or the "Project") in Nevada. Mammoth Minerals Limited (ASX: M79) ("Mammoth") has been aggressively exploring Excelsior pursuant to its option agreement to earn an 80% interest in the Project over five years, providing Athena a free-carry to Definitive Feasibility Study thereafter (see Company press releases dated June 2, 2025, and August 22, 2025).
Toronto, Ontario--(Newsfile Corp. - August 11, 2026) - Athena Gold Corporation (CSE: ATHA) (OTCQB: AHNRF) ("Athena" or the "Company") is pleased to announce that it has further consolidated its land position at its 100%-owned Forester project in Ontario's Musselwhite Gold Camp. Through recent map staking, the Company acquired an additional 6,088 hectares of contiguous mining claims, expanding the project by approximately 69% to a total of 14,930 hectares.
Toronto, Ontario--(Newsfile Corp. - August 6, 2026) - Athena Gold Corporation (CSE: ATHA) (OTCQB: AHNRF) ("Athena" or the "Company") is pleased to announce the appointment of Mr. Farid Mammadov, CPIR, as Vice President, Investor Relations of the Company, effective immediately.